| mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.001 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.004 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.006 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.006 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.006 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.007 |